How Many Doses Vial GHK-Cu? (Reconstitution Math)

How Many Doses Vial GHK-Cu? (Reconstitution Math)

A single 5mg vial of GHK-Cu doesn't contain a predetermined number of doses. It contains 5mg of lyophilized peptide that yields anywhere from 10 to 50 doses depending entirely on how you reconstitute it. The number of doses vial GHK-Cu delivers is determined by your target dose per injection and the volume of bacteriostatic water you use for reconstitution, not by the vial size itself. Most researchers make the mistake of treating vial size as dose count, leading to either wasteful dilution or dangerously concentrated solutions.

How many doses vial GHK-Cu provides depends on reconstitution volume and target dose per injection. A 5mg vial reconstituted with 2mL bacteriostatic water at 100mcg per dose yields 50 administrations, while the same vial at 500mcg per dose yields 10. The peptide amount is fixed; the dose count is entirely under your control through dilution.

This isn't about guessing. It's about calculating concentration based on the amino acid sequencing precision that defines research-grade peptides. Real Peptides produces GHK-Cu through small-batch synthesis with exact sequencing, meaning the 5mg labeled on your vial is a reliable starting point for dose math, not an approximation. The rest of this piece covers exactly how reconstitution volume determines dose count, the concentration ranges used in published studies, what preparation mistakes invalidate your entire batch, and how to calculate your specific dose yield before you inject the first unit of bacteriostatic water.

Reconstitution Volume Controls Dose Count, Not Vial Size

The number of doses vial GHK-Cu provides is a function of three variables: peptide mass (typically 5mg), reconstitution volume (usually 1–5mL bacteriostatic water), and target dose per injection (commonly 100–500mcg in research protocols). A 5mg vial reconstituted with 1mL bacteriostatic water creates a 5mg/mL solution. At a 100mcg target dose, you draw 0.02mL (20 units on an insulin syringe) per administration, yielding 50 doses. The same vial reconstituted with 5mL creates a 1mg/mL solution. At 500mcg per dose, you draw 0.5mL per administration, yielding 10 doses. The peptide quantity hasn't changed; the concentration and dose count are entirely determined by how much water you add.

This is not intuitive to most researchers new to peptide protocols. In our experience working with research teams across peptide applications, the most common error is assuming 'one vial equals one treatment cycle' without performing the actual concentration calculation. GHK-Cu (glycyl-L-histidyl-L-lysine complexed with copper) is a tripeptide chelate with a molecular weight of approximately 340 Da. Meaning 5mg equals roughly 14.7 micromoles of peptide. When you reconstitute that with bacteriostatic water, you're not creating discrete doses; you're creating a homogenous solution from which you extract your target dose volume based on the concentration you've engineered.

The calculation is straightforward: final concentration (mg/mL) = peptide mass (mg) ÷ reconstitution volume (mL). From there, dose volume (mL) = target dose (mg) ÷ final concentration (mg/mL). If you're working with a 5mg vial and want 200mcg (0.2mg) doses, reconstitute with 2mL bacteriostatic water to create a 2.5mg/mL solution, then draw 0.08mL per dose. Yielding 25 administrations per vial. Every additional milliliter of bacteriostatic water you add reduces your final concentration proportionally and increases the volume you must draw per dose.

Bacteriostatic water. Sterile water containing 0.9% benzyl alcohol as a preservative. Is the standard reconstitution vehicle for lyophilized peptides because it inhibits bacterial growth for up to 28 days under refrigeration at 2–8°C. Do not use sterile saline, tap water, or distilled water; the absence of bacteriostatic preservation increases contamination risk with every needle puncture. Once reconstituted, store the vial upright in the refrigerator, never in the freezer. Freezing denatures the peptide structure. If you need to extend shelf life beyond 28 days, reconstitute only the volume you'll use within that window and keep the remaining lyophilized powder frozen at −20°C until needed.

Published Research Uses 100–500mcg Dose Ranges for Tissue Repair Models

The target dose per injection. And therefore the number of doses vial GHK-Cu yields. Should be informed by published research protocols in your application area. A review of GHK-Cu studies in wound healing, collagen synthesis, and inflammatory modulation shows dose ranges from 100mcg to 500mcg per administration in animal models, with some dermatological applications using concentrations as low as 50mcg for localized topical injection. At 100mcg per dose, a 5mg vial reconstituted to optimal concentration provides 50 administrations; at 500mcg per dose, the same vial provides 10 administrations. This five-fold range means dose count is not a vial specification. It's a protocol design choice.

GHK-Cu's mechanism of action involves binding to cellular receptors that activate tissue remodeling genes, particularly those involved in extracellular matrix synthesis and metalloproteinase regulation. The copper ion in the chelate complex is essential to this activity. GHK without copper shows markedly reduced bioactivity in collagen deposition assays. Studies published in peer-reviewed journals including the Journal of Investigative Dermatology and Wound Repair and Regeneration have used subcutaneous injection doses between 0.1mg and 1mg per kilogram body weight in rodent models, with dose-response curves showing maximal collagen synthesis at mid-range concentrations and plateau effects at higher doses. For a 250g rat, that translates to 25–250mcg per injection. The same range many research teams use as starting points when scaling protocols.

In practice, this means your dose count per vial depends on whether your research model prioritizes lower, more frequent dosing (which increases dose count per vial but requires more frequent administration) or higher, less frequent dosing (which reduces dose count but may simplify dosing schedules). We've guided research teams through this exact calculation across multiple peptide protocols, and the pattern is consistent: researchers who calculate dose count before reconstitution achieve better batch consistency than those who reconstitute first and adjust dosing afterward.

The half-life of subcutaneously administered GHK-Cu in circulation is relatively short. Studies report plasma clearance within hours. But its effects on gene expression and protein synthesis persist for days to weeks beyond the initial injection. This pharmacokinetic profile explains why many protocols use every-other-day or three-times-weekly dosing rather than daily administration. If your protocol involves 30 administrations over 10 weeks at 200mcg per dose, you need 6mg total peptide. Meaning a single 5mg vial is insufficient. Calculate total peptide requirement (dose × administrations) before ordering, not after your first vial runs out mid-protocol.

Concentration Math: Converting Peptide Mass to Injection Volume

Calculating how many doses vial GHK-Cu provides requires converting peptide mass to liquid volume. A step where most preparation errors occur. Start with the labeled peptide mass (typically 5mg), decide your target dose per injection (e.g., 200mcg), then calculate the reconstitution volume that makes your target dose easy to measure with standard insulin syringes. Most research teams use 0.3mL (30-unit) or 0.5mL (50-unit) syringes with 1-unit graduations, meaning the smallest measurable increment is 0.01mL. If your calculated dose volume falls below 0.02mL, you're working at the edge of syringe precision. Dilute further.

Here's the step-by-step: (1) Convert your target dose to milligrams (200mcg = 0.2mg). (2) Decide your desired dose volume. Ideally between 0.05mL and 0.3mL for accurate measurement (let's choose 0.1mL). (3) Calculate required concentration: 0.2mg ÷ 0.1mL = 2mg/mL. (4) Calculate reconstitution volume: 5mg peptide ÷ 2mg/mL = 2.5mL bacteriostatic water. (5) Calculate total doses: 5mg ÷ 0.2mg per dose = 25 doses. That's the complete workflow. Every other method is a variation of this sequence.

The biggest mistake we see is reconstituting first, then realizing the resulting concentration requires drawing 0.01mL per dose. A volume so small that measurement error exceeds 10%. If you've already reconstituted a 5mg vial with 5mL bacteriostatic water (creating a 1mg/mL solution) and need 100mcg doses, you're attempting to draw 0.1mL. Manageable but at the high end of practical volume for subcutaneous injection. If you need 50mcg doses from the same concentration, you're drawing 0.05mL. Workable, but pushing measurement limits. The solution is to plan concentration around your target dose before adding water, not after.

Insulin syringes display volume in units, with 100 units equaling 1mL. If your calculated dose volume is 0.08mL, you draw to the 8-unit mark. If your syringe only has graduations every 2 units, round your dose to the nearest measurable increment. Attempting to 'eyeball' intermediate volumes introduces 15–25% variance. For doses requiring volumes below 0.05mL, either increase your concentration (use less bacteriostatic water) or increase your per-dose peptide amount. Precision matters because GHK-Cu shows dose-dependent effects in published studies. Underdosing by 30% may shift your results below the threshold for observable collagen synthesis.

One additional variable: peptide purity. Real Peptides lyophilized peptides are synthesized to >98% purity by HPLC, meaning a 5mg vial contains at least 4.9mg active GHK-Cu. Generic suppliers often list 'net peptide content' separately from gross weight. A 5mg vial at 80% purity contains only 4mg active compound, reducing your actual dose count by 20%. If your vendor doesn't specify purity, assume lower active content and adjust calculations accordingly or risk underdosing your entire protocol.

How Many Doses Vial GHK-Cu: Concentration Comparison

The table below shows how reconstitution volume determines dose count for a standard 5mg GHK-Cu vial across three common target doses. Use this to plan your reconstitution volume before opening the vial.

Notice that total dose count remains constant at 25 for the 200mcg target regardless of reconstitution volume. Concentration changes, draw volume changes, but total administrations stay fixed because the peptide mass hasn't changed. The choice of reconstitution volume is about measurement convenience and injection volume preference, not about increasing dose count. If you want more doses from a single vial, reduce your per-dose peptide amount, not your reconstitution volume.

Key Takeaways

• A 5mg GHK-Cu vial yields 10–50 doses depending on your target dose per injection. Not on vial size.
• Reconstitution volume controls concentration (mg/mL), which determines the liquid volume you draw per dose.
• Published research protocols use 100–500mcg per administration in tissue repair models; dose count scales inversely with target dose.
• Calculate your total peptide requirement (dose × number of administrations) before ordering to avoid running out mid-protocol.
• Use bacteriostatic water, not saline or distilled water, and store reconstituted vials at 2–8°C for up to 28 days maximum.
• Plan your reconstitution volume around your target dose to keep draw volumes between 0.05–0.3mL for accurate syringe measurement.

What If: GHK-Cu Dosing Scenarios

What If I Reconstituted with Too Much Bacteriostatic Water?

You cannot remove water once added. The solution is now permanently at the diluted concentration. If you added 5mL instead of 2mL, your concentration dropped from 2.5mg/mL to 1mg/mL, meaning you must draw 2.5× the volume per dose. If this pushes your draw volume above 0.5mL per injection, you have two options: accept the larger injection volume (subcutaneous injections tolerate up to 1mL but cause more site discomfort) or reduce your per-dose peptide amount to bring volume back into a manageable range. The peptide is not wasted, but your dose count per vial is now fixed at the lower concentration. Recalculate total doses and order additional vials if needed to complete your protocol.

What If I Need Doses Smaller Than My Syringe Can Measure?

If your calculated dose volume is 0.01mL (1 unit) or less, you're below the practical measurement threshold for standard insulin syringes. Dilute further by adding more bacteriostatic water. This reduces concentration and increases the volume you draw per dose. For example, if a 100mcg dose at 5mg/mL concentration requires drawing 0.02mL, reconstitute with 2mL instead of 1mL to create a 2.5mg/mL solution, increasing your draw volume to 0.04mL. Still precise but now measurable. Alternatively, increase your target dose if your research protocol allows it. Never attempt to 'estimate' sub-graduation volumes by guessing between syringe marks. Measurement variance will exceed your dose amount.

What If My Reconstituted Vial Looks Cloudy After Mixing?

GHK-Cu should reconstitute to a clear, pale blue solution. Cloudiness indicates precipitation, contamination, or denaturation. Do not inject cloudy peptide solution. Causes include: using non-bacteriostatic water, exceeding storage temperature during shipping, or adding water too aggressively and creating foam. If cloudiness appears immediately upon reconstitution, the peptide may have degraded before you opened it. Temperature excursions above 25°C during shipping denature lyophilized copper peptides. Contact your supplier with photos. If cloudiness develops days after reconstitution despite proper refrigeration, bacterial contamination is likely. Discard the vial, do not attempt to filter or salvage it.

The Calculated Truth About GHK-Cu Dose Yield

Here's the honest answer: the question 'how many doses vial GHK-Cu' has no fixed answer unless you specify target dose and reconstitution volume. A 5mg vial is not 10 doses or 25 doses or 50 doses. It's 5mg of peptide that you convert into whatever dose count your protocol requires through controlled dilution. Researchers who treat vial size as dose count are either working from imprecise protocols or didn't perform the concentration math before starting. Every reputable research protocol specifies dose in milligrams or micrograms per administration, not 'one vial per week'. If your source material uses vial-based dosing, find a better source.

The peptide doesn't care how many doses you want. It will deliver exactly the mass you inject regardless of how you've divided the vial. Underdosing by diluting too much shifts your results below published effective concentrations. Overdosing by concentrating too little volume into each injection wastes peptide and increases cost per administration unnecessarily. The correct approach is to define your target dose from literature, calculate the reconstitution volume that makes that dose measurable, then determine how many administrations your vial provides at that concentration. This is basic stoichiometry applied to peptide research. The math is not optional.

One additional consideration researchers often miss: vial overfill. Many peptide suppliers, including Real Peptides, include 5–10% overfill to account for loss during reconstitution and drawing. A 5mg vial may contain 5.3–5.5mg actual peptide, giving you 1–2 extra doses beyond your calculated count. Do not rely on overfill to meet your total protocol requirement. Treat it as a buffer for measurement error, not as guaranteed extra doses. Plan peptide orders based on labeled mass, and consider overfill a margin of safety for the final administrations when you're drawing from a nearly empty vial and leaving residual solution behind.

The difference between a researcher who calculates dose count before reconstitution and one who guesses after adding water is the difference between a reproducible protocol and one that 'sort of worked but we're not sure why.' If you're investing in research-grade peptides, invest the 60 seconds required to calculate your exact dose yield before you puncture the vial stopper.

Understanding reconstitution math extends across the entire peptide research field. Our full peptide collection includes compounds with varying stability profiles and concentration requirements. Some, like BPC-157, tolerate a wide range of working concentrations, while others require tighter control. The same calculation discipline that determines how many doses vial GHK-Cu provides applies to every lyophilized peptide you reconstitute. Master the math once, apply it everywhere.

If you're working at the threshold where measurement precision matters. Doses below 100mcg, volumes below 0.05mL. Consider whether your protocol would benefit from higher per-dose amounts within published effective ranges. A 200mcg dose is easier to measure accurately than a 75mcg dose, and if both fall within effective concentration windows from literature, the higher dose simplifies preparation without compromising results. Precision is valuable, but so is reproducibility. A slightly higher dose measured accurately beats a theoretically optimal dose measured poorly every single administration.